The Aroon Indicator for ACCS entered a downward trend on October 16, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 247 similar instances where the Aroon Indicator formed such a pattern. In 219 of the 247 cases the stock moved lower. This puts the odds of a downward move at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.597) is normal, around the industry mean (-1.016). P/E Ratio (-10.133) is within average values for comparable stocks, (18.241). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (1.501). Dividend Yield (0.000) settles around the average of (0.083) among similar stocks. P/S Ratio (0.830) is also within normal values, averaging (1.860).
The Tickeron Seasonality Score of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. ACCS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
The RSI Oscillator for PGNY moved out of oversold territory on September 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 42 similar instances when the indicator left oversold territory. In 37 of the 42 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on PGNY as a result. In 69 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for PGNY just turned positive on October 07, 2026. Looking at past instances where PGNY's MACD turned positive, the stock continued to rise in 36 of 51 cases over the following month. The odds of a continued upward trend are 71%.
PGNY moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PGNY crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +6.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where PGNY advanced for three days, in 233 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 143 of 211 cases where PGNY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGNY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
PGNY broke above its upper Bollinger Band on October 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating fairly steady price growth. PGNY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.929) is normal, around the industry mean (3.582). P/E Ratio (30.333) is within average values for comparable stocks, (130.390). PGNY's Projected Growth (PEG Ratio) (0.090) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. PGNY's P/S Ratio (1.816) is very high in comparison to the industry average of (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PGNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
ACCS | PGNY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 53 | |
PRICE GROWTH RATING 1..100 | 82 | 39 | |
P/E GROWTH RATING 1..100 | 17 | 49 | |
SEASONALITY SCORE 1..100 | 43 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACCS's Valuation (24) in the Data Processing Services industry is somewhat better than the same rating for PGNY (77) in the null industry. This means that ACCS’s stock grew somewhat faster than PGNY’s over the last 12 months.
ACCS's Profit vs Risk Rating (100) in the Data Processing Services industry is in the same range as PGNY (100) in the null industry. This means that ACCS’s stock grew similarly to PGNY’s over the last 12 months.
PGNY's SMR Rating (53) in the null industry is somewhat better than the same rating for ACCS (92) in the Data Processing Services industry. This means that PGNY’s stock grew somewhat faster than ACCS’s over the last 12 months.
PGNY's Price Growth Rating (39) in the null industry is somewhat better than the same rating for ACCS (82) in the Data Processing Services industry. This means that PGNY’s stock grew somewhat faster than ACCS’s over the last 12 months.
ACCS's P/E Growth Rating (17) in the Data Processing Services industry is in the same range as PGNY (49) in the null industry. This means that ACCS’s stock grew similarly to PGNY’s over the last 12 months.
| ACCS | PGNY | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 88% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 80% |
| Momentum ODDS (%) | N/A | 1 day ago 73% |
| MACD ODDS (%) | N/A | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 76% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 77% |
| Advances ODDS (%) | N/A | 3 days ago 76% |
| Declines ODDS (%) | 4 days ago 78% | 7 days ago 80% |
| BollingerBands ODDS (%) | N/A | 1 day ago 76% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 68% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACCS’s FA Score shows that 2 FA rating(s) are green while PGNY’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACCS’s TA Score shows that 1 TA indicator(s) are bullish while PGNY’s TA Score has 7 bullish TA indicator(s).
ACCS (@Advertising/Marketing Services) experienced а -2.98% price change this week, while PGNY (@Managed Health Care) price change was +2.16% for the same time period.
The average weekly price growth across all stocks in the @Advertising/Marketing Services industry was -2.29%. For the same industry, the average monthly price growth was -6.85%, and the average quarterly price growth was +0.58%.
The average weekly price growth across all stocks in the @Managed Health Care industry was +2.42%. For the same industry, the average monthly price growth was +10.34%, and the average quarterly price growth was +42.86%.
ACCS is expected to report earnings on Nov 10, 2026.
PGNY is expected to report earnings on Nov 05, 2026.
Making a brand known to people, garnering more clients/consumers for its product and solidifying the brand’s position in an industry – all of these are essential to a company’s growth, and that’s where marketing/advertising come in as one of the key catalysts. Advertising industry is a global multibillion-dollar business of public relations and marketing companies, media services and advertising agencies – entities that help to connect manufacturers/producers with customers. Digital media has played a big role in the growth of global advertising, and agencies invest substantially to integrate advanced technologies into their business operations. According to some estimates, the U.S. advertising industry is expected to generate revenue of $52.6 billion by 2023, up from almost $40 billion in 2015 . Omnicom Group Inc., Trade Desk, Inc. and Interpublic Group of Companies, Inc. are some of the major U.S. companies in the industry.
@Managed Health Care (+2.42% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
A.I.dvisor tells us that ACCS and DCBO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACCS and DCBO's prices will move in lockstep.
| Ticker / NAME | Correlation To ACCS | 1D Price Change % | ||
|---|---|---|---|---|
| ACCS | 100% | +0.12% | ||
| DCBO - ACCS | 31% Poorly correlated | +0.23% | ||
| AKAM - ACCS | 26% Poorly correlated | +0.95% | ||
| MGNI - ACCS | 25% Poorly correlated | -2.07% | ||
| PGNY - ACCS | 25% Poorly correlated | +2.39% | ||
| SSNC - ACCS | 23% Poorly correlated | +2.81% | ||
More | ||||
A.I.dvisor indicates that over the last year, PGNY has been loosely correlated with CLSK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PGNY jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To PGNY | 1D Price Change % | ||
|---|---|---|---|---|
| PGNY | 100% | +2.39% | ||
| CLSK - PGNY | 54% Loosely correlated | -6.86% | ||
| COIN - PGNY | 53% Loosely correlated | -4.51% | ||
| RIOT - PGNY | 48% Loosely correlated | -8.06% | ||
| HOOD - PGNY | 39% Loosely correlated | -5.25% | ||
| COMP - PGNY | 36% Loosely correlated | +2.57% | ||
More | ||||